Literature DB >> 30055523

Low-grade endometrial stromal sarcoma presenting as multiple pulmonary nodules: A potential pitfall in fine needle aspiration and core biopsy specimens - A Cytological - Pathological Correlation.

Shira Ronen1, Navneet Narula2, June H Koizumi3, Bryan Hunt4, Tamara Giorgadze5.   

Abstract

Low-grade endometrial stromal sarcoma (LGESS) is the second most common malignant mesenchymal tumor of the uterus. The most common location is the uterine corpus, but it can also primarily arise in a variety of extrauterine locations such as pelvis, ovary, abdominal cavity, vagina, and vulva. We are reporting a case of a 47-year-old female with no significant medical history who presented with multiple pulmonary nodules. Fine needle aspiration (FNA) specimen revealed spindle cell neoplasm consistent with the diagnosis of LGESS. The differential diagnosis included neuroendocrine tumor, synovial sarcoma, solitary fibrous tumor, smooth muscle tumors, and peripheral nerve sheath tumors. The clinical, cytological, and histopathologic details of this case, as well as a discussion of the potential pitfalls and differential diagnosis of spindle cell lesions of the lung are described.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fine needle aspiration; Leiomyosarcoma; Low-grade endometrial stromal sarcoma; Neuroendocrine tumor; Solitary fibrous tumor; Synovial sarcoma

Mesh:

Year:  2018        PMID: 30055523     DOI: 10.1016/j.anndiagpath.2018.06.004

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  2 in total

1.  Educational Case: Metastatic endometrial stromal sarcoma presenting as bone pain: a diagnostic approach to uterine mesenchymal tumors.

Authors:  Terri E Jones; Samer Khader; Mirka W Jones; Sigfred B Lajara
Journal:  Acad Pathol       Date:  2022-05-13

Review 2.  Primary low-grade extrauterine endometrial stromal sarcoma: analysis of 10 cases with a review of the literature.

Authors:  You Wu; Nan Li; Rong Zhang; Ping Bai
Journal:  World J Surg Oncol       Date:  2022-01-13       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.